CPT code 53855 covers insertion of a sterile, disposable urethral stent placed to prevent collapse of the urethra and maintain urinary flow, most commonly used to support the prostatic urethra after obstructive swelling from treatment for benign prostatic hyperplasia (BPH). This procedure is clinically significant because it addresses acute postoperative urinary obstruction and can reduce the need for catheterization or repeat procedures, with implications for patient recovery and resource use across surgical settings.

Key payers included in the national analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how CPT code 53855 is billed across typical sites of service (ambulatory surgical centers and hospital operating rooms) and by urology specialists.

Readers will find concise benchmarks and contextual information on utilization patterns, coding considerations, and the clinical circumstances prompting stent insertion for prostatic urethral support. The summary highlights common billing modifiers and payer mix considerations where available. Data not available in the input are noted where relevant. The content is intended to inform coding, billing, and policy stakeholders about the clinical role and administrative handling of CPT code 53855 at a national level.